CAPTRUST FINANCIAL ADVISORS - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$77,000
+381.2%
6,690
+441.7%
0.00%
Q1 2022$16,000
+23.1%
1,235
+13.0%
0.00%
Q4 2021$13,000
+44.4%
1,093
+56.4%
0.00%
Q3 2021$9,000
-10.0%
699
-7.0%
0.00%
Q2 2021$10,000
-76.2%
752
-79.8%
0.00%
Q1 2021$42,000
+4100.0%
3,722
+7057.7%
0.00%
Q4 2020$1,000520.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders